Fluticasone / Umeclidinium / Vilanterol
- MDIFluticasone / Umeclidinium / VilanterolTrelegy Ellipta
Mechanism of Action
- Contains a long-acting muscarinic agent (LAMA) and a long-acting beta 2 agonist (LABA) as bronchodilators, as well as an inhaled corticosteroid (ICS) to reduce airway inflammation.
- Maintenance therapy for COPD.
- Adverse Effects
- Oesophageal candidiasis
- Dry mouth